MarketCap
Facebook
X
TelegramQuartalsbericht 2022-Q2
hinzugefügt 18.08.2022
Land |
 Deuschland |
IPO-Jahr |
2020 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
186 M |
Marktkapitalisierung |
$ 867 M |
EBITDA (LTM) |
$ -131 M |
P/E (LTM) |
-7.54 |
P/S (LTM) |
- |
EPS (LTM) |
-0.7 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Burford Capital Limited
BUR
|
$ 4.74 | 0.53 % | $ 761 M | NYSE |  Britain |
 |
Cabaletta Bio
CABA
|
$ 3.33 | 2.15 % | $ 335 M | Nasdaq Global Select Market |  USA |
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market | Germany |
 |
Can-Fite BioPharma Ltd.
CANF
|
$ 3.07 | 0.49 % | $ 5.05 M | NYSE American |  Israel |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
$ 332.58 | -2.01 % | $ 43.6 B | Nasdaq Global Select Market,SPB | USA |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market |  China |
 |
Alterity Therapeutics Limited
ATHE
|
$ 3.8 | 4.97 % | $ 9.14 B | Nasdaq Capital Market |  Australia |
 |
AlloVir
ALVR
|
- | 4.14 % | $ 49.1 M | Nasdaq Global Select Market | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Genfit SA
GNFT
|
- | 2.54 % | $ 160 B | Nasdaq Global Select Market |  France |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market | France |
 |
Aligos Therapeutics
ALGS
|
$ 7.51 | -14.07 % | $ 74.2 M | Nasdaq Global Select Market | USA |
 |
Allakos
ALLK
|
- | - | $ 28.6 M | Nasdaq Global Select Market,SPB | USA |
 |
Esperion Therapeutics
ESPR
|
$ 2.11 | 2.77 % | $ 439 M | Nasdaq Global Market,SPB | USA |
 |
Evogene Ltd.
EVGN
|
$ 0.82 | - | $ 27.9 M | Nasdaq Global Market | Israel |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
Applied Molecular Transport
AMTI
|
- | - | $ 10.1 M | Nasdaq Global Select Market,SPB | USA |
|
Forte Biosciences
FBRX
|
$ 32.35 | -0.2 % | $ 419 M | Nasdaq Capital Market | USA |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market | Britain |
 |
Applied Therapeutics
APLT
|
- | - | $ 8.42 M | Nasdaq Global Market,SPB | USA |
 |
Aptinyx
APTX
|
- | -39.0 % | $ 4.57 M | Nasdaq Global Select Market | USA |
 |
Aravive
ARAV
|
- | -13.39 % | $ 1.45 M | Nasdaq Global Select Market | USA |
 |
Galapagos NV
GLPG
|
$ 28.99 | 0.36 % | $ 2.69 B | Nasdaq Global Select Market |  Belgium |
 |
Amphastar Pharmaceuticals
AMPH
|
$ 21.36 | -0.09 % | $ 998 M | Nasdaq Global Select Market | USA |
 |
Genmab A/S
GMAB
|
$ 29.02 | -0.14 % | $ 18.6 B | Nasdaq Global Select Market |  Danmark |
 |
GT Biopharma
GTBP
|
$ 0.38 | -3.34 % | $ 2.1 M | Nasdaq Capital Market | USA |
 |
BioNTech SE
BNTX
|
$ 99.43 | 1.03 % | $ 27.2 B | Nasdaq Global Select Market | Germany |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | USA |
 |
Hoth Therapeutics
HOTH
|
$ 0.68 | 4.58 % | $ 9.39 M | Nasdaq Global Select Market | USA |
 |
Aeterna Zentaris
AEZS
|
- | 5.93 % | $ 314 M | Nasdaq Capital Market |  Canada |
 |
Harmony Biosciences Holdings
HRMY
|
$ 29.37 | 0.27 % | $ 1.69 B | Nasdaq Global Select Market | USA |
 |
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | USA |
 |
ImmuCell Corporation
ICCC
|
$ 7.61 | -1.55 % | $ 68.7 M | Nasdaq Global Select Market | USA |
 |
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | USA |
 |
Akebia Therapeutics
AKBA
|
$ 1.54 | -1.28 % | $ 396 M | Nasdaq Global Market | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | USA |
 |
Aquestive Therapeutics
AQST
|
$ 4.18 | 0.6 % | $ 447 M | Nasdaq Global Market | USA |
 |
Arcutis Biotherapeutics
ARQT
|
$ 24.39 | -2.79 % | $ 3.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Brainstorm Cell Therapeutics
BCLI
|
- | -2.5 % | $ 5.88 M | Nasdaq Capital Market | USA |
|
Immatics N.V.
IMTX
|
$ 10.9 | -0.46 % | $ 686 M | Nasdaq Global Select Market | Germany |
 |
AIkido Pharma
AIKI
|
- | 1.93 % | $ 17.4 M | Nasdaq Capital Market | USA |
 |
Incyte Corporation
INCY
|
$ 97.43 | -0.27 % | $ 19 B | Nasdaq Global Select Market,SPB | USA |
 |
BioDelivery Sciences International
BDSI
|
- | -4.8 % | $ 255 M | Nasdaq Global Select Market | USA |
 |
Autolus Therapeutics plc
AUTL
|
$ 1.46 | -1.49 % | $ 389 M | Nasdaq Global Select Market | Britain |
 |
Aptose Biosciences
APTO
|
- | -45.71 % | $ 1.2 M | Nasdaq Capital Market | Canada |
 |
BeiGene, Ltd.
BGNE
|
- | 0.49 % | $ 251 B | Nasdaq Global Select Market |  Cayman-islands |
 |
Innate Pharma S.A.
IPHA
|
$ 1.71 | 4.91 % | $ 235 M | Nasdaq Global Select Market | France |